Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: BigKNY3 who wrote (6387)	11/30/1998 9:49:00 PM
From: BigKNY3	Read Replies (1) \| Respond to of 9523

The Big Pharma Report: November 1998 Have PFun! BigKNY3 _________________________________________ Big Pharma Review -After reaching an all-time high on Friday (86.13), profit-taking took Big Pharma (-2.1%) and the market (-2.3%) down. Every Big Pharma declined. -During November, Big Pharma gained 4.4% as compared to larger gains for the Dow (+6.1%), S&P (+5.9%) and the Internet crazy NASTie (+10.1%). -For the month, MRK (+14.9%) was the sector leader based on the Vioxx NDA submission and a declared 2-1 split. Other double digit gains were recorded by LLY (+10.7%) and BMY (+10.6%). Laggards for the month were SBH (-4.4%) and AMGN (-4.2%). -Reflecting a good response to the 11/6/98 R&D meeting and no reaction to a revision in the Viagra package insert, PFE gained 4.3% for the month. -YTD, Big Pharma (+41.4%) is clearly outpacing all major general markets (Dow:+15.3%, S&P:19.9% and NASTie: +24.2%). Every Big Pharma is currently over 18.5%. - In the YTD race, SGP (+71.8%) is once again making a run at WLA (+83.3%). -PFE (+50.1%) has jumped back into the #3 spot...the same rank as in 1997. _________________________________________________________ PFE Analyst Report of the Month Bear Stearns- November 25, 1998 "The changes FDA made to four key sections of Viagra's label reflect data from real world use. Key additions to the label include warnings about cardiovascular risks, nitrate drug interaction, priapism, and high-risk user profiles, most of which is already in the public domain. Importantly, the FDA continues to state that they perceive Viagra as safe when used as instructed. Further, next month's American Heart Association guidelines on Viagra use will be substantially in-line with the revised label. Prescribing patterns are unlikely to change dramatically as this news is disseminated since awareness levels about Viagra's safety profile are high among medical professionals due to considerable media attention received thus far. We are leaving our Viagra sales estimates unchanged in the face of what we perceive as a non-event, reserving the right to fine-tune our numbers if the situation changes in the future. .....In our view, unrealistic expectations for Viagra are no longer reflected in the stock as most analysts have been lowering their estimates." PFE Comparative Charts This Weeks' PFE Price Action versus the Dow. quicken.com PFE versus the Dow since the NDA submission for Viagra. quicken.com Analysts' Roll-Call - Broker Ratings Summary quicken.com -Norby Broker Reports nordby.com PFE Upgrades and Downgrades biz.yahoo.com Market Environment Links -Briefing.com Market Updates briefing.com Summary of last Week's Market Action biz.yahoo.com -Briefing.com Market Environment briefing.com Investment Websites and Databases CBS MarketWatch: PFE News cbs.marketwatch.com Dailystocks PFE Database dailystocks.com - Link to free Merrill Lynch Reports (Only registration is required through 2/28/98) askmerrill.com Investment Advice 8 easy ways to lose your shirt in stocks usatoday.com IBD: 26 Weeks to Investing ibd.infostreet.com Big Pharma News Links Yahoo Link quote.yahoo.com Motley Fool Link quote.fool.com Labpuppy Drug Stock Commentary (scroll down the page) labpuppy.com ED News Links Yahoo Link quote.yahoo.com Motley Fool Link quote.fool.com AOL Viagra Link aol://4344:2441.viagra.25954287.585682429 Alt.Support.Impotence aol://5863:126/alt.support.impotence Yahoo Viagra Link headlines.yahoo.com PFE Price History (1987-1998) Updated: 11/30/98 -Average December PFE growth is +1.5% over the last 6 years. Yearly Growth (1987-1998) -PFE has increased for 5 consecutive years -PFE has increased more than tenfold in the 1990s Year Ending..... PFE......% Chg . Date................ Price.....Prior Year....Comments 12/31/87...........5.82......-25.0%....... Bear market/market crash 12/30/88...........7.25.......24.7% 12/29/89........... 8.69......19.9% 12/31/90..........10.10.......16.2% 12/31/91..........21.00.......108.0%.....2-1 split (2/91) 12/31/92..........18.13......-13.7%......Clinton elected president 12/31/93......... 17.25.......-4.8%.......Healthcare reform pending 12/30/94......... 19.32.......12.0% 12/29/95..........31.50.......63.1% ......2-1 split (6/95) 12/30/96..........41.50.......31.7% 12/31/97..........74.56.......79.7% ......2-1 split (6/30/97) 11/30/98......... 111.94......50.1%.......Viagra approved (3/27/98) Quarter to Quarter Growth ....Quarter........ PFE..... % Chg . ........Date.........Price.....Prior Qt........Comments 1st Qt, 1993......15.75....-13.1% 2nd Qt, 1993......16.75....6.3% 3rd Qt, 1993......14.88....-11.2% 4th Qt, 1993......17.25.....16.0% 1st Qt, 1994......13.50....-21.7%....Healthcare reform pending 2nd Qt, 1994.....15.80.....17.0% 3rd Qt, 1994......17.29.....9.4% 4th Qt, 1994......19.33.....11.8% 1st Qt, 1995......21.44.....10.9% 2nd Qt, 1995......23.06....7.5%....2-1 split (6/95) 3rd Qt, 1995.......26.67.....15.6% 4th Qt, 1995.......31.50.....18.1% 1st Qt, 1996.......33.63..... 6.7% 2nd Qt, 1996......35.67........6.1% 3rd Qt, 1996.......39.56......10.9% 4th Qt, 1996.......41.50........4.9% 1st Qt, 1997.......42.06........1.4% 2nd Qt, 1997......59.88.......42.3%.... 2-1 split (6/30/97) 3rd Qt, 1997.......60.25.........0.6% 4th Qt, 1997.......74.56........23.8%....Trovan approved (12/97) 1st Qt, 1998.......99.88.........33.9%....Viagra approved (3/27/98) 2nd Qt, 1998......108.69..... ..8.8%.......Viagra sales $411M 3rd Qt, 1998.......105.75.......-2.7% 4th Qt, 1998.......111.94.......+5.9% Monthly and Quarterly Averages (1993-1998) ................Avg % Chg .................93-98 January ...... 3.4% February.....-2.8% March........ 1.8% April.......... 8.0% May.......... 3.1% June......... 2.8% July.......... -1.1% August ..... -1.3% September...4.9% October..... 8.2% November....4.7% December....1.5% ......................Avg % Chg ....................... 93-98 First Quarter........3.0% Second Quarter..14.7% Third Quarter........3.8% Fourth Quarter....12.5%